Titan Pharmaceuticals, Inc.
IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE
Last updated:
Abstract:
The invention provides implantable drug delivery devices comprising a core comprising a polymer (or polymer blend) and one or more drugs or pharmaceutical substances, and an outer shell comprising a polymer (or polymer blend) and one or more porogen materials. The invention reduces burst release of drug. Pharmaceuticals such as triiodothyronine (T3) or ropinirole can be delivered by the devices.
Status:
Application
Type:
Utility
Filling date:
5 Oct 2017
Issue date:
14 Jan 2021